by GlobeNewsWire | Dec 22, 2015 | Globe Newswire
VANCOUVER, British Columbia, Dec. 22, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewswireCanada | Dec 16, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Dec. 16, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | Dec 16, 2015 | Globe Newswire
VANCOUVER, British Columbia, Dec. 16, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewswireCanada | Dec 10, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Dec. 10, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | Dec 10, 2015 | Globe Newswire
VANCOUVER, British Columbia, Dec. 10, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...